| scholarly article | Q13442814 |
| P50 | author | Matthew L Senjem | Q30505707 |
| Clifford Jack | Q30505709 | ||
| Kejal Kantarci | Q83230766 | ||
| Stephen Weigand | Q88487393 | ||
| Val J. Lowe | Q107200019 | ||
| Heather J Wiste | Q107208807 | ||
| Ronald C. Petersen | Q56839853 | ||
| David S Knopman | Q63967707 | ||
| Bradley F Boeve | Q67501037 | ||
| P2093 | author name string | M M Shiung | |
| B J Kemp | |||
| A R Frank | |||
| P2860 | cites work | Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain | Q25855787 |
| Neuropathologic features of amnestic mild cognitive impairment | Q28238965 | ||
| Unified segmentation | Q29616050 | ||
| Alzheimer's disease diagnosis in individual subjects using structural MR images: validation studies | Q30481978 | ||
| The role of biomarkers in clinical trials for Alzheimer disease | Q31032781 | ||
| Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI | Q80071452 | ||
| Early detection of Alzheimer's disease using neuroimaging | Q31048702 | ||
| Antemortem MRI based STructural Abnormality iNDex (STAND)-scores correlate with postmortem Braak neurofibrillary tangle stage | Q33345777 | ||
| The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics | Q33650976 | ||
| Comparative evaluation of MR-based partial-volume correction schemes for PET. | Q33885188 | ||
| Natural history of mild cognitive impairment in older persons | Q34140726 | ||
| Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. | Q34244667 | ||
| Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease | Q34509732 | ||
| Automated template-based PET region of interest analyses in the aging brain | Q35688912 | ||
| Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cerebrovascular disease in mild cognitive impairment subtypes | Q37345411 | ||
| Hippocampal formation glucose metabolism and volume losses in MCI and AD. | Q43668221 | ||
| Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome | Q43788870 | ||
| Differences in cerebral metabolic impairment between early and late onset types of Alzheimer's disease | Q44071354 | ||
| Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease? | Q44411562 | ||
| Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study | Q44452244 | ||
| Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment | Q44571913 | ||
| Subcortical vascular versus amnestic mild cognitive impairment: comparison of cerebral glucose metabolism | Q46236216 | ||
| What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia? | Q46349482 | ||
| Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease | Q46407740 | ||
| Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients | Q46486075 | ||
| Comparison of 18F-FDG PET and optimized voxel-based morphometry for detection of Alzheimer's disease: aging effect on diagnostic performance | Q46897706 | ||
| Mixed brain pathologies account for most dementia cases in community-dwelling older persons | Q48136681 | ||
| Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia | Q48550309 | ||
| Synapse loss is greater in presenile than senile onset Alzheimer disease: implications for the cognitive reserve hypothesis | Q48582964 | ||
| Age, neuropathology, and dementia | Q48597534 | ||
| Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease | Q48671019 | ||
| FDG PET imaging in patients with pathologically verified dementia. | Q52023258 | ||
| Mayo Clinic Alzheimer's Disease Patient Registry. | Q52054751 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mild cognitive impairment | Q1472703 |
| cognitive dysfunction | Q57859955 | ||
| P304 | page(s) | 1247-1253 | |
| P577 | publication date | 2010-03-18 | |
| P1433 | published in | American Journal of Neuroradiology | Q15762571 |
| P1476 | title | Effects of age on the glucose metabolic changes in mild cognitive impairment | |
| P478 | volume | 31 |
| Q33740879 | 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons |
| Q40649206 | Age and neurodegeneration imaging biomarkers in persons with Alzheimer disease dementia |
| Q31138018 | Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using 18F-FDG-PET. |
| Q35732274 | Alzheimer's disease - not an exaggeration of healthy aging |
| Q28085139 | Alzheimer's disease: Unique markers for diagnosis & new treatment modalities |
| Q39258299 | Biomarkers for Early Diagnosis of Alzheimer's Disease in the Oldest Old: Yes or No? |
| Q57457546 | CRISPR/Cas9-mediated disruption of SHANK3 in monkey leads to drug-treatable autism-like symptoms |
| Q58740989 | Characteristic patterns of inter- and intra-hemispheric metabolic connectivity in patients with stable and progressive mild cognitive impairment and Alzheimer's disease |
| Q55400177 | Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer's dementia. |
| Q35550633 | Concurrent hippocampal induction of MHC II pathway components and glial activation with advanced aging is not correlated with cognitive impairment |
| Q48506103 | Cortical hypermetabolism in MCI subjects: a compensatory mechanism? |
| Q36763368 | Effect of intellectual enrichment on AD biomarker trajectories: Longitudinal imaging study |
| Q55214530 | Effects of metformin on the cerebral metabolic changes in type 2 diabetic patients. |
| Q47772310 | Emerging Roles of Sirtuin 6 in Alzheimer's Disease |
| Q46602955 | Empirical derivation of the reference region for computing diagnostic sensitive ¹⁸fluorodeoxyglucose ratios in Alzheimer's disease based on the ADNI sample |
| Q90326103 | Exposure to surgery with general anaesthesia during adult life is not associated with increased brain amyloid deposition in older adults |
| Q37164817 | Focal hemosiderin deposits and β-amyloid load in the ADNI cohort |
| Q48778159 | Functional integration changes in regional brain glucose metabolism from childhood to adulthood. |
| Q89373176 | Impact of the Presence of Select Cardiovascular Risk Factors on Cognitive Changes among Dementia Subtypes |
| Q34064379 | Improved DTI registration allows voxel-based analysis that outperforms tract-based spatial statistics |
| Q35926305 | Inclusion criteria provide heterogeneity in baseline profiles of patients with mild cognitive impairment: comparison of two prospective cohort studies |
| Q60046879 | Laboratory and Neuroimaging Biomarkers in Neuropsychiatric Systemic Lupus Erythematosus: Where Do We Stand, Where To Go? |
| Q34964670 | MRS in mild cognitive impairment: early differentiation of dementia with Lewy bodies and Alzheimer's disease |
| Q37141684 | Mild cognitive impairment: an update in Parkinson's disease and lessons learned from Alzheimer's disease |
| Q35785744 | Multimodality imaging characteristics of dementia with Lewy bodies |
| Q39286812 | Olfactory Identification Deficits, Cognitive Decline, and Dementia in Older Adults |
| Q34451903 | Olfactory deficits predict cognitive decline and Alzheimer dementia in an urban community |
| Q34715043 | Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies |
| Q64104581 | Region-specific association between basal blood insulin and cerebral glucose metabolism in older adults |
| Q37656554 | The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives |
| Q35007780 | The hippocampal neuroproteome with aging and cognitive decline: past progress and future directions. |
| Q36882294 | p53-dependent SIRT6 expression protects Aβ42-induced DNA damage |
Search more.